High pressure liquid chromatographic analysis and preliminary pharmacokinetics of sulfaphenazole and its N2-glucuronide and N4-acetyl metabolites in plasma and urine of man

@article{Vree2005HighPL,
  title={High pressure liquid chromatographic analysis and preliminary pharmacokinetics of sulfaphenazole and its N2-glucuronide and N4-acetyl metabolites in plasma and urine of man},
  author={T. Vree and E. W. B. Beneken Kolmer and Y. Hekster},
  journal={Pharmaceutisch Weekblad},
  year={2005},
  volume={12},
  pages={243-246}
}
  • T. Vree, E. W. B. Beneken Kolmer, Y. Hekster
  • Published 2005
  • Medicine
  • Pharmaceutisch Weekblad
    • A direct high pressure liquid chromatographic analysis of sulfaphenazole-N2-glucuronide in urine is described. After an oral dose of 439 mg of sulfaphenazole, 0% is excreted unchanged in the urine, < 1% is excreted as N4-acetylsulfaphenazole. As N2-glucuronide 49.4% is excreted in one slow acetylator and 84.8% in one fast acetylator. 
    View on Springer
    ncbi.nlm.nih.gov
    7 Citations

    Figures and Topics from this paper

    Figures

    Explore Further: Topics Discussed in This Paper

    7 Citations
    Citation Type

    Citation Type

    Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans
    • 7
    Direct high pressure liquid chromatographic analysis and preliminary pharmacokinetics of enantiomers of oxazepam and temazepam with their corresponding glucuronide conjugates
    • 12
    Direct gradient reversed-phase HPLC analysis and preliminary pharmacokinetics of nalidixic acid, 7-hydroxymethylnalidixic acid, 7-carboxynalidixic acid, and their corresponding glucuronide conjugates in humans
    • 5
    Capacity-limited renal glucuronidation of probenecid by humans
    • 12
    Quantitative Prediction of In Vivo Drug-Drug Interactions from In Vitro Data Based on Physiological Pharmacokinetics: Use of Maximum Unbound Concentration of Inhibitor at the Inlet to the Liver
    • 123
    Comparison of different approaches to predict metabolic drug–drug interactions
    • 20
    Comparison of different approaches to predict metabolic drug-drug interactions.
    • H. Einolf
    • Chemistry, Medicine
    • Xenobiotica; the fate of foreign compounds in biological systems
    • 2007
    • 97

    References

    SHOWING 1-10 OF 34 REFERENCES
    High-performance liquid chromatography of sulphadimethoxine and its N1-glucuronide, N4-acetyl and N4-acetyl-N1-glucuronide metabolites in human plasma and urine.
    • 22
    Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs
    • 5
    Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfamethomidine in humans
    • 8
    Studies on metabolism of drugs. 8. On the glucuronide of sulfaphenazole in human.
    • 4
    Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment
    • 9
    Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man
    • 3
    The role of plasma protein binding on the metabolism and renal excretion of sulphadimethoxine and its metabolite N4-acetylsulphadimethoxine in pigs.
    • 20
    Renal clearance of sulphinpyrazone in man
    • 1
    Species differences in the metabolism of sulphadimethoxine.
    • 47
    SULFAPHENAZOL (ORISUL), A LONG‐ACTING ANTIBACTERIAL SULFONAMIDE
    • W. Boger
    • Medicine
    • Journal of the American Geriatrics Society
    • 1959
    • 4